Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial

PURPOSE: Diabetic peripheral neuropathic pain (DPNP) is one of the most sufferings, disabling, and dominant complications of diabetes. Duloxetine (DLX) and Pregabalin (PGB) are among first-line therapy and the most prescribed drugs for DPNP relief. The effectiveness-risk profile of drugs may differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Joharchi, Khojasteh, Memari, Moosareza, Azargashb, Eznollah, Saadat, Navid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915178/
https://www.ncbi.nlm.nih.gov/pubmed/31890684
http://dx.doi.org/10.1007/s40200-019-00427-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915178/
https://www.ncbi.nlm.nih.gov/pubmed/31890684
http://dx.doi.org/10.1007/s40200-019-00427-w

Ejemplares similares